HIMS & HERS HEALTH INC (HIMS) Stock Price, Quote, News and Overview
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
HIMS Quote, Performance and Key Statistics
61.21
-1.13 (-1.81%)
The current stock price of HIMS is 61.21 USD. In the past month the price increased by 141.25%. In the past year, price increased by 269.31%.
HIMS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11.77 | 88.11B | ||
| CVS | CVS HEALTH CORP | 10.02 | 80.46B | ||
| LH | LABCORP HOLDINGS INC | 17.03 | 20.99B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.39 | 19.90B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 18.77 | 17.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 134.11 | 14.56B | ||
| DVA | DAVITA INC | 15.78 | 11.20B | ||
| CHE | CHEMED CORP | 24.67 | 8.51B | ||
| CRVL | CORVEL CORP | 27.19 | 5.84B | ||
| OPCH | OPTION CARE HEALTH INC | 26.67 | 5.42B | ||
| GH | GUARDANT HEALTH INC | N/A | 4.95B | ||
| RDNT | RADNET INC | 286.48 | 4.51B |
Related stock screener links
About HIMS
Company Profile
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,637 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Company Info
HIMS & HERS HEALTH INC
2269 Chestnut St, #523
San Francisco CALIFORNIA 94123 US
CEO: Andrew Dudum
Employees: 1637
Phone: 14158510195
HIMS & HERS HEALTH INC / HIMS FAQ
What is the stock price of HIMS & HERS HEALTH INC today?
The current stock price of HIMS is 61.21 USD. The price decreased by -1.81% in the last trading session.
What is the ticker symbol for HIMS & HERS HEALTH INC stock?
The exchange symbol of HIMS & HERS HEALTH INC is HIMS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is HIMS stock listed?
HIMS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for HIMS & HERS HEALTH INC stock?
21 analysts have analysed HIMS and the average price target is 43.48 USD. This implies a price decrease of -28.96% is expected in the next year compared to the current price of 61.21. Check the HIMS & HERS HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HIMS & HERS HEALTH INC worth?
HIMS & HERS HEALTH INC (HIMS) has a market capitalization of 13.69B USD. This makes HIMS a Large Cap stock.
How many employees does HIMS & HERS HEALTH INC have?
HIMS & HERS HEALTH INC (HIMS) currently has 1637 employees.
Is HIMS & HERS HEALTH INC (HIMS) expected to grow?
The Revenue of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 60.2% in the next year. Check the estimates tab for more information on the HIMS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HIMS & HERS HEALTH INC (HIMS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HIMS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HIMS, evaluating the profitability, health, valuation and growth aspects
- HIMS & HERS HEALTH INC (HIMS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HIMS & HERS HEALTH INC (HIMS) Sales and EPS estimates to see what analysts future expectations are.
- HIMS & HERS HEALTH INC (HIMS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HIMS & HERS HEALTH INC (HIMS) Insider and Institutional Ownership to learn about the owners and their transactions.
- HIMS & HERS HEALTH INC (HIMS) Stock Chart to make your own analysis
- HIMS & HERS HEALTH INC (HIMS) Latest news and press-releases to stay up to date.
Does HIMS & HERS HEALTH INC (HIMS) stock pay dividends?
HIMS does not pay a dividend.
When does HIMS & HERS HEALTH INC (HIMS) report earnings?
HIMS & HERS HEALTH INC (HIMS) will report earnings on 2025-08-04, after the market close.
What is the Price/Earnings (PE) ratio of HIMS & HERS HEALTH INC (HIMS)?
The PE ratio for HIMS & HERS HEALTH INC (HIMS) is 88.71. This is based on the reported non-GAAP earnings per share of 0.69 and the current share price of 61.21 USD. Check the full fundamental report for a full analysis of the valuation metrics for HIMS.
What is the Short Interest ratio of HIMS & HERS HEALTH INC (HIMS) stock?
The outstanding short interest for HIMS & HERS HEALTH INC (HIMS) is 32.85% of its float. Check the ownership tab for more information on the HIMS short interest.
HIMS Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to HIMS. When comparing the yearly performance of all stocks, HIMS is one of the better performing stocks in the market, outperforming 98.94% of all stocks.
HIMS Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to HIMS. While HIMS has a great health rating, its profitability is only average at the moment.
HIMS Financial Highlights
Over the last trailing twelve months HIMS reported a non-GAAP Earnings per Share(EPS) of 0.69. The EPS increased by 7000% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.21% | ||
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| Debt/Equity | 0 |
HIMS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 69% to HIMS. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 17.11% and a revenue growth 60.2% for HIMS